Infographic: How Aware of Biosimilars are US Rheumatologists?

A recent survey of US rheumatologists found that there is room for improvement in clinicians' awareness of biosimilar therapies. 
The Center for Biosimilar Staff
November 12, 2017
A recent survey of US rheumatologists found that there is room for improvement in clinicians' awareness of biosimilar therapies. 

infographic showing physician's awareness and opinions of biosimilars.

 

x-button

Health economics experts. Managed care professionals. Key clinical specialists. This is where the worlds of clinical, regulatory, and economical outcomes for specialized pharmaceutical biotechnology meet: The Center for Biosimilars is your online resource for emerging technologies, with a focus on improving critical thinking in the field to impact patient outcomes. We’ll discuss the current landscape for advanced health care management—reviewing emerging treatment paradigms, approaches, and considerations—all by authoritative industry voices.

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright © 2006-2019 Intellisphere, LLC. All Rights Reserved.